Simon Khagi, Jose Arganda Carrillo, David J. Park, Courtney Lewis, Leylah Drusbosky, Paul Bhar, Lian Hong, Lennie Sender, Sandeep Bobby Reddy, Santosh Kesari, Patrick Soon-Shiong. "Response in first-in-human chemotherapy-free combination immunotherapy targeting lymphopenia in recurrent glioblastoma multiform (GBM): Nogapendekin alfa inbakicept (NAI) and PD-L1 t-haNK plus bevacizumab (BEV).." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.16_suppl.e14079